People · Operator
Named in public records as an officer, director or promoter · active 2020–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| JumpCode Genomics, Inc. | — | Biotechnology | Series B | $38.7M | $23.4M | 2020 |
Yaron Hakak at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Yaron Hakak on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Liang | 1 | 9 |
| Eugene Chen | 1 | 9 |
| Keith Brown | 1 | 8 |
| Court Turner | 1 | 6 |
| Kevin Li | 1 | 4 |
| Dan Kidle | 1 | 4 |
| Frank Witney | 1 | 3 |
| Kirk Malloy | 1 | 2 |
| Joel Rotroff | 1 | 2 |
| Brandon Poe | 1 | 2 |
| David Michael Salter | 1 | 1 |
| Court Michael Turner | 1 | 1 |
| Joseph Michael Lee | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.